Health Catalyst Inc
NASDAQ:HCAT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Health Catalyst Inc
NASDAQ:HCAT
|
US |
|
QuickLogic Corp
NASDAQ:QUIK
|
US |
|
Amgen Inc
NASDAQ:AMGN
|
US |
|
M
|
MSCI Inc
F:3HM
|
US |
|
A
|
Altria Group Inc
XMUN:PHM7
|
US |
|
E
|
Eni SpA
F:ENI
|
IT |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
F:MOHF
|
FR |
|
H
|
Hyatt Hotels Corp
XMUN:1HTA
|
US |
|
ASM International NV
AEX:ASM
|
NL |
|
Woolworths Holdings Ltd
OTC:WLWHY
|
ZA |
|
Arvind Ltd
BSE:500101
|
IN |
|
A
|
Adidas AG
SWB:ADS
|
DE |
|
Harmony Gold Mining Company Ltd
F:HAM1
|
ZA |
|
A
|
Asahi Kasei Corp
SWB:ASAA
|
JP |
|
V
|
VICI Properties Inc
F:1KN
|
US |
Wall St Price Targets
HCAT Price Targets Summary
Health Catalyst Inc
According to Wall Street analysts, the average 1-year price target for
HCAT is 1.86 USD with a low forecast of 1.52 USD and a high forecast of 2.1 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HCAT's stock price target?
Price Target
1.86
USD
According to Wall Street analysts, the average 1-year price target for
HCAT is 1.86 USD with a low forecast of 1.52 USD and a high forecast of 2.1 USD.
What is the Revenue forecast for Health Catalyst Inc?
Projected CAGR
-10%
Over the last 7 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 3 years is -10%.
What is the Gross Profit forecast for Health Catalyst Inc?
Projected CAGR
-19%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 2 years is -19%.